Picture of PolarCool AB logo

POLAR PolarCool AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly Speculative

Momentum

Relative Strength (%)
1m-17.88%
3m-46.68%
6m-44.75%
1yr-72.94%
Volume Change (%)
10d/3m+166.06%
Price vs... (%)
52w High-75.6%
50d MA-20.37%
200d MA-37.46%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS  /

Blurred out image of PolarCool AB EPS forecast chart

Profile Summary

Polarcool AB is a Sweden-based medical device company specializing in sports medicine. The Company focuses on of concussive and sub-concussive brain injuries. It develops a portable brain cooling device called PolarCap System. The PolarCap System consists of a cooling unit and a silicone-based cooling cap alongside neoprene insulation, cooling the head and neck via a circulating coolant during a procedure that takes approximately 45-60 minutes. The idea behind it is the reduction of brain temperature of individuals suffering from a concussion or participating in an activity where repetitive head impact occurs, such as contact and combat sports, in order to prevent or limit long term cognitive impairment. The device undergoes preclinical cohort study for concussion among hockey players and a preclinical study for indication of sub-concussive repetitive head impact among American football players.

Directors

    Last Annual
    Last Interim
    Incorporated
    January 1st, 1970
    Public Since
    November 27th, 2018
    Sector
    Biotechnology & Medical Research
    Industry
    Healthcare
    Exchange
    se flag iconAktieTorget Stock Exchange
    Shares in Issue
    3,592,236

    POLAR Share Price Performance

    Similar to POLAR

    Picture of Abera Bioscience AB logo

    Abera Bioscience AB

    se flag iconAktieTorget Stock Exchange

    Picture of Aptahem AB logo

    Aptahem AB

    se flag iconAktieTorget Stock Exchange

    Picture of Arcede Pharma AB logo

    Arcede Pharma AB

    se flag iconAktieTorget Stock Exchange

    Picture of Carbiotix AB (publ) logo

    Carbiotix AB (publ)

    se flag iconAktieTorget Stock Exchange

    Picture of Chosa Oncology AB logo

    Chosa Oncology AB

    se flag iconAktieTorget Stock Exchange

    FAQ